Publication | Closed Access
NIR Bioimaging: Development of Liposome‐Encapsulated, Rare‐Earth‐Doped Y<sub>2</sub>O<sub>3</sub> Nanoparticles as Fluorescent Probes
62
Citations
23
References
2010
Year
NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringNanomedicineTherapeutic NanomaterialsBioimagingNir BioimagingBiophysicsFluorescent ProbesBiomedicineNanobiotechnologyNirfluorescence ImagesBiophotonicsCeramic NanoparticlesNanodiscSingle-molecule DetectionBiomolecular EngineeringBiomedical DiagnosticsBiomedical ImagingPharmaceutical NanotechnologyDrug Delivery SystemsMedicineFluorescence Bioimaging
Abstract Near‐infrared (NIR) bioimaging is attracting a lot of attention due to the absence of strong scattering and color fading of the phosphors, which can provide long‐term and deep imaging. For fluorescence bioimaging (FBI) in the NIR region, rare‐earth‐doped ceramic nanoparticles can be one of the best candidates. For the delivery of the ceramic particles to the biological imaging target, liposome‐encapsulating the ceramic phosphor is proposed. Liposome‐encapsulated, Er‐doped Y 2 O 3 nanoparticles were prepared as fluorescent probes for NIR bioimaging. Their surface was modified with PEG, biotin, anionic, and cationic agents. The dispersion, surface charge, and specific interactions of the surface‐modified liposomes were characterized. Microscopic and macroscopic NIR bioimages were demonstrated by injecting the liposome‐encapsulated, Er‐doped Y 2 O 3 nanoparticles into the body of a mouse through the blood vessels. The NIRfluorescence images of the mouse organs are presented.
| Year | Citations | |
|---|---|---|
Page 1
Page 1